Showing results (471-480 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanomaSteven A Rosenberg, James C Yang, Paul F Robbins, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinomaBarbara J Gitlitz, Arie S Belldegrun, Amnon Zisman, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Antitumor reactivity of anti-CD3/anti-CD28 bead-activated lymphoid cells: implications for cell therapy in a murine modelFumito Ito, Abbey Carr, Hakan Svensson, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapyUluhan Sili, M Helen Huls, Alan R Davis, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Generation of melanoma-specific cytotoxic T lymphocytes for allogeneic immunotherapyAnnette Nolte, Christian Scheffold, Janina Slotty, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12Bohuslav Melichar, Renato Lenzi, Michael Rosenblum, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Serum total ganglioside level correlates with clinical course in melanoma patients after immunotherapy with therapeutic cancer vaccineMepur H Ravindranath, Eddy C Hsueh, Meena Verma, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant gliomaGentao Liu, Hung T Khong, Christopher J Wheeler, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Heterogeneity in the human response to immunostimulatory CpG oligodeoxynucleotidesCynthia A Leifer, Daniela Verthelyi, Dennis M KlinmanJournal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
LEC/chTNT-3 fusion protein for the immunotherapy of experimental solid tumorsJiali Li, Peisheng Hu, Leslie A Khawli, et al.Pageof 176